Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Surgical Research|December 22, 2014
Proof of prometastatic niche induction by hepatic stellate cellsClarisse Eveno, Patricia Hainaud, Aurore Rampanou, et al.
Virology|March 4, 2009
Activation of the lytic program of the Epstein-Barr virus in Burkitt's lymphoma cells leads to a two steps downregulation of expression of the proapoptotic protein BimEL, one of which is EBV-late-gene expression dependentLassad Oussaief, Aurélie Hippocrate, Cyril Clybouw, et al.
The Journal of Biological Chemistry|July 11, 2009
Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivationLassad Oussaief, Aurélie Hippocrate, Vanessa Ramirez, et al.
Ultrasound in Medicine & Biology|May 1, 2012
Tumor and non-tumor liver angiogenesis is traced and evaluated by hepatic arterial ultrasound in murine modelsClarisse Eveno, Carole Le Henaff, Raphaëlle Audollent, et al.
The American Journal of Pathology|March 17, 2011
Netrin-4 delays colorectal cancer carcinomatosis by inhibiting tumor angiogenesisClarisse Eveno, Dong Broqueres-You, Jean-Guillaume Feron, et al.
Analytical Chemistry|May 4, 2026
Circulating Tumor DNA Monitoring in Patients with Uveal Melanoma Using Mutation-Agnostic Multiplex Drop-Off ddPCR AssaysAurore Rampanou, Manuel Rodrigues, François-Clément Bidard, et al.
Cancers|April 23, 2022
Deciphering HER2-HER3 Dimerization at the Single CTC Level: A Microfluidic ApproachEzgi Tulukcuoglu Guneri, Emile Lakis, Ismail Hajji, et al.
British Journal of Cancer|January 21, 2021
Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trialLuc Cabel, Frédérique Berger, Paul Cottu, et al.
International Journal of Cancer|August 13, 2013
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanomaFrançois-Clément Bidard, Jordan Madic, Pascale Mariani, et al.
Diagnostic and Interventional Imaging|March 3, 2026
Total tumor volume and growth rate at 3 months on MRI outperform baseline imaging and circulating tumor DNA for predicting survival of patients with metastatic uveal melanoma receiving tebentafuspToulsie Ramtohul, Xavier-Louis Jasawant, José Luis Sandoval, et al.
Pageof 3